DLL4-blocking antibodies resulted in excessive, dysregulated angiogenesis and the formation of abnormal blood vessels that were ineffective at transporting nutrients, thereby inhibiting tumor growth in preclinical models [147]. The gene discussed is DLL4; the disease is neoplasm.